NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases
Under the terms of the agreement, Novo Nordisk and NanoVation [...]
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
Tivic Health reports this clinical research collaboration with Feinstein is [...]
Harnessing the Power of the Heart and Mind: Overcoming Atrial Fibrillation and Launching a Business | By Jim Kaveney
Jim Kaveney writes: “In both entrepreneurship and managing AFib, I [...]
ACEP to CMS: Require Hospital Plans to Address Boarding in Emergency Departments
ACEP proposes that CMS update its emergency services Condition of [...]
John Beeler Appointed SVP of Business Development at BPGbio
Dr. John Beeler is a seasoned biopharma executive with extensive [...]
Christopher Whitmore Appointed CFO at Ray Therapeutics
Christopher Whitmore is a highly accomplished executive who brings over [...]
Andy Fuller Appointed VP of Market Access at AESAR
With over 27 years of experience in the pharmaceutical industry, [...]
Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy
“Receiving both Orphan Drug and Rare Pediatric Disease Designations for [...]
Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
MindLight is the first circular RNA biomarker-based assay designed to [...]
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
“The Decipher Prostate test’s ability to help guide treatment for [...]